Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (39)
COVID-19 (12)
Type
Type
Guidance (1866)
NICE advice (323)
Quality standard (198)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (223)
COVID-19 rapid guidelines (3)
Diagnostics guidance (47)
Health technology evaluations (18)
Highly specialised technologies guidance (28)
Interventional procedures guidance (601)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (339)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (766)
Advice programme
Advice programme
Evidence summaries (68)
Medtech innovation briefings (255)
Apply filters
Showing 321 to 330 of 2387
Sort by
Date
Title
Apply sorting
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Bulevirtide for treating chronic hepatitis D
TA896
7 June 2023
7 June 2023
Burosumab for treating X-linked hypophosphataemia in children and young people
HST8
10 October 2018
10 October 2018
Butterfly iQ+ for diagnostic ultrasound imaging
MIB254
4 March 2021
4 March 2021
C3 glomerulopathy in the native kidney: eculizumab
ESUOM49
22 December 2015
22 December 2015
Cabazitaxel for hormone-relapsed metastatic prostate cancer treated with docetaxel
TA391
25 May 2016
24 August 2016
Cabotegravir with rilpivirine for treating HIV-1
TA757
5 January 2022
5 January 2022
Cabozantinib for previously treated advanced differentiated thyroid cancer unsuitable for or refractory to radioactive iodine
TA928
1 November 2023
1 November 2023
Cabozantinib for previously treated advanced hepatocellular carcinoma
TA849
14 December 2022
14 December 2022
Cabozantinib for previously treated advanced renal cell carcinoma
TA463
9 August 2017
9 August 2017
Cabozantinib for treating medullary thyroid cancer
TA516
28 March 2018
28 March 2018
Previous page
1
…
31
32
Current page
33
34
35
…
239
Page
33
of
239
Next page
Results per page
10
25
50
All
Back to top